Position in HLN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$790
-$8 QoQ
Shares Held
79
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Manchester Capital Management LLC holds $190,507 across 8 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
4,649 | $74,523 | |
| 2 | VTRS |
Viatris Inc
|
4,478 | $71,110 | |
| 3 | ZTS |
Zoetis Inc.
|
500 | $35,930 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
119 | $2,928 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4 | $2,167 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11 | $1,853 | |
| 7 | ALKS |
Alkermes plc.
|
20 | $1,048 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
28 | $948 |
All Filings in HLN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $790 | 79 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $798 | 79 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $839 | 81 | Shares | Sole | 2025-08-12 | |
| 2024-03-31 | $849 | 100 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $823 | 100 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $833 | 100 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $838 | 100 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $814 | 100 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $800 | 100 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,811 | 790 | Shares | Sole | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||